Mabwell’s experimental therapy 9MW1911 may reduce the frequency of moderate to severe exacerbations in people with chronic obstructive…
Articles by Marisa Wexler, MS
The American Lung Association Research Institute is investing $22 million to advance research and support care for lung disease,…
A Phase 3 clinical trial testing AstraZeneca’s injection therapy benralizumab as a potential treatment for chronic obstructive…
Genentech has announced mixed top-line results from two global clinical trials testing its treatment candidate astegolimab in people with…
The U.S. Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for certain people with…
The U.S. Food and Drug Administration (FDA) has approved Abrysvo, a vaccine that protects against lung infections caused by the…
The U.S. Food and Drug Administration (FDA) has granted breakthrough designation to tezepelumab, an approved therapy for severe asthma, as…
People who get more vitamin E from their diet may be less likely to develop chronic obstructive pulmonary disease…
The U.S. Food and Drug Administration (FDA) has approved Verona Pharma’s ensifentrine as an inhaled maintenance therapy for adults with…
A new campaign will highlight the ways certain jobs, including those related to mining, agriculture, and manufacturing, can increase the…